German Health Minister Under Fire

6 November 1995

The German Health Minister, Horst Seehofer, has come under fire from the national hospitals association for claiming that hospitals are the main source of rising health care costs. Mr Seehofer has spoken of possible savings in the sector of 5-6 billion Deutschemarks ($3.74-$4.25 billion), but the association says it is disappointed with his attitude.

Despite considerable expansion of hospital services, their share of total health fund spending has remained stable, falling from 32.5% to 31.9% last year in western Germany and from 31.6% to 31.4% in the eastern states, it says. In first-half 1995, hospital treatment spending rose at a below-average rate of 6.1% in western germany and 11.3% in the east.

The association also notes that since 1993, the average length of stay in hospital has fallen by 7.8%, while 93 hospitals have closed and beds have been cut by 57,000 in the period between 1990 and 1993.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight